Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
insulin human (humulin) (1 trial)
vildagliptin (1 trial)
bortezomib (velcade) (1 trial)
cabazitaxel (jevtana kit) (1 trial)
melphalan (alkeran) (1 trial)
apricot (1 trial)
essential oils (2 trials)
Adenocarcinoma (Phase 3)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 2 (Phase 4)
Multiple Myeloma (Phase 3)
Neoplasms, Plasma Cell (Phase 3)
Prostatic Neoplasms (Phase 3)
Recurrence (Phase 3)
Trials (5 total)
Trial APIs (7 total)